Literature DB >> 2925062

Endoscopic biliary therapy using the combined percutaneous and endoscopic technique.

J F Dowsett1, D Vaira, A R Hatfield, S R Cairns, A Polydorou, R Frost, J Croker, P B Cotton, R C Russell, R R Mason.   

Abstract

Between September 1985 and December 1987, 74 patients underwent attempted endoscopic biliary therapy using a combined percutaneous transhepatic and endoscopic transpapillary approach (combined procedure). All patients had had failed endoscopy-alone procedures and had contraindications to surgery. The indication was palliation of malignant biliary obstruction in 66 cases (41 common bile duct, 25 hilar), assistance with sphincterotomy for the removal of common bile duct stones in 6 cases, and management of benign biliary stenosis in 2 cases. The initial procedure was percutaneous transhepatic access to the biliary tree, which was successful in all but 1 case (99%). The bile duct was drained externally for an average of 3.4 days before the combined procedure. One patient died during this period from hemorrhage associated with liver puncture. Combined procedure was performed in 72 cases and was successful in 60 [53 malignant stricture (53/66 = 80%), five common duct stone (5/6 = 83%), two benign stricture (2/2 = 100%)]. Procedure-related morbidity and mortality, respectively, were 12.5% and 0% for benign disease and 36% and 3% for malignant disease. The total (initial endoscopy included) morbidity and 30-day mortality were 33% and 0%, respectively, for benign disease and 62% and 27% for malignant disease. Subsequently, stent change has been required on 16 occasions, with endoscopy-only successful in 13 (81%) and repeat combined procedure being required in three (19%). The combined procedure improves the ability of endoscopy to offer nonsurgical therapy to poor risk patients with both malignant and benign biliary disease but is associated with significant morbidity and disease-related mortality.

Entities:  

Mesh:

Year:  1989        PMID: 2925062     DOI: 10.1016/0016-5085(89)91639-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  53 in total

Review 1.  Precut sphincterotomy: indications, pitfalls, and complications.

Authors:  C J Larkin; K Huibregtse
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  Endoscopic therapy for biliary obstruction.

Authors:  N Soehendra; K F Binmoeller; H Grimm
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

3.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Cholangiocarcinoma.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

5.  Palliation of malignant obstructive jaundice--surgery or stent?

Authors: 
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

6.  Laparoscopic choledochojejunostomy via PTFE-covered stent successfully achieves internal drainage of common bile duct obstruction.

Authors:  Leonardo Villegas; Daniel Jones; Guy Lindberg; Craig Chang; Seifu Tesfay; Jason B Fleming
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 7.  Role of endoscopy in primary sclerosing cholangitis.

Authors:  Nabeel S Koro; Samer Alkaade
Journal:  Curr Gastroenterol Rep       Date:  2013-12

8.  Endoscopic "crossroads" in the management of malignant hilar strictures.

Authors:  Shajan Peter; Charles M Wilcox
Journal:  Indian J Gastroenterol       Date:  2013-10-26

9.  Usefulness of the rendezvous technique for biliary stricture after adult right-lobe living-donor liver transplantation with duct-to-duct anastomosis.

Authors:  Jae Hyuck Chang; In Seok Lee; Ho Jong Chun; Jong Young Choi; Seung Kyoo Yoon; Dong Goo Kim; Young Kyoung You; Myung-Gyu Choi; Kyu-Yong Choi; In-Sik Chung
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

10.  A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction.

Authors:  H Isayama; Y Komatsu; T Tsujino; N Sasahira; K Hirano; N Toda; Y Nakai; N Yamamoto; M Tada; H Yoshida; Y Shiratori; T Kawabe; M Omata
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.